Orchard Therapeutics Plc Stock Filter Stocks by Fundamentals
ORTXDelisted Stock | USD 5.27 0.01 0.19% |
Orchard Therapeutics PLC fundamentals help investors to digest information that contributes to Orchard Therapeutics' financial success or failures. It also enables traders to predict the movement of Orchard Stock. The fundamental analysis module provides a way to measure Orchard Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orchard Therapeutics stock.
Orchard |
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Orchard Fundamentals
Return On Equity | -0.72 | |||
Return On Asset | -0.29 | |||
Operating Margin | (3.43) % | |||
Current Valuation | 302.52 M | |||
Shares Outstanding | 22.76 M | |||
Shares Owned By Insiders | 12.20 % | |||
Shares Owned By Institutions | 87.80 % | |||
Number Of Shares Shorted | 27.2 K | |||
Price To Earning | (8.06) X | |||
Price To Book | 4.74 X | |||
Price To Sales | 17.41 X | |||
Revenue | 21.84 M | |||
Gross Profit | (76.52 M) | |||
EBITDA | (99.34 M) | |||
Net Income | (72.92 M) | |||
Cash And Equivalents | 170.89 M | |||
Cash Per Share | 1.35 X | |||
Total Debt | 58.09 M | |||
Debt To Equity | 0.41 % | |||
Current Ratio | 4.24 X | |||
Book Value Per Share | 3.53 X | |||
Cash Flow From Operations | (93.32 M) | |||
Short Ratio | 0.29 X | |||
Earnings Per Share | (4.10) X | |||
Target Price | 16.0 | |||
Number Of Employees | 166 | |||
Beta | 0.55 | |||
Market Capitalization | 380.11 M | |||
Total Asset | 218.91 M | |||
Retained Earnings | (900.88 M) | |||
Working Capital | 107.58 M | |||
Current Asset | 300.47 M | |||
Current Liabilities | 46.52 M | |||
Z Score | -2.64 | |||
Net Asset | 218.91 M |
About Orchard Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orchard Therapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orchard Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orchard Therapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Orchard Stock
If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |